A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)
Clinical trial NCT01708174 · COMPLETED
Trial details
- NCT number
- NCT01708174
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-06
- Primary completion
- 2016-10-05
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.